Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection
暂无分享,去创建一个
S. Spector | E. Barr | S. Nichols | M. Purswani | G. Seage | D. Persaud | R. Yogev | P. Garvie | S. Brummel | W. Shearer | E. McFarland | M. Paul | S. Burchett | K. Patel | K. Malee | P. Harding | Megan L. Wilkins | A. Wiznia | A. Puga | G. Scott | K. Knapp | Priyanka Uprety | Maria Garcia Bulkley | P. Sirois | J. Blood | M. Grant | K. Allison | B. Kammerer | M. Silió | B. Karalius | S. Siminski | C. Ziemniak | M. Nozyce | Lynnette L. Harris | R. Van Dyke | M. Sanders | Scott Hunter | N. Cooper | Mahboobullah Baig | Anna Cintron | S. Navarro | N. Karthas | M. Burey | A. Dieudonne | L. Bettica | Latreaca Ivey | Midnela Acevedo‐Flores | Heida Rios | Vivian Olivera | K. Norris | Juliana Darrow | Y. Chen | Janet S. Chen | M. Gabriel | Grace Alvarez | Anai Cuadra | L. Ivey
[1] R. Dewar,et al. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy , 2016, Proceedings of the National Academy of Sciences.
[2] M. Lichterfeld,et al. Diversity of HIV-1 reservoirs in CD4+ T-cell subpopulations , 2016, Current opinion in HIV and AIDS.
[3] E. Mick,et al. Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants , 2016, PloS one.
[4] S. Lewin,et al. Paediatric HIV infection: the potential for cure , 2016, Nature Reviews Immunology.
[5] S. Hughes,et al. Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo , 2016, Proceedings of the National Academy of Sciences.
[6] R. Phillips,et al. Immunological biomarkers predict HIV-1 viral rebound after treatment interruption , 2015, Nature Communications.
[7] M. Johnson,et al. Author response: Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs , 2015 .
[8] G. Yenokyan,et al. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] J. Mellors,et al. Early Antiretroviral Therapy in South African Children Reduces HIV-1-Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells. , 2015, The Journal of infectious diseases.
[10] C. Rouzioux,et al. Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] A. Haase,et al. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption , 2015, Proceedings of the National Academy of Sciences.
[12] D. Persaud,et al. Very early combination antiretroviral therapy in infants: prospects for cure , 2015, Current opinion in HIV and AIDS.
[13] D. Richman,et al. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents. , 2014, JAMA pediatrics.
[14] J. Mellors,et al. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] M. Carrington,et al. HIV-1 DNA predicts disease progression and post-treatment virological control , 2014, eLife.
[16] S. Hughes,et al. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells , 2014, Science.
[17] J. Ananworanich,et al. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children , 2014, AIDS.
[18] Feng Fu,et al. Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 , 2014, Proceedings of the National Academy of Sciences.
[19] Sarah B. Laskey,et al. Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.
[20] D. Pillay,et al. The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection , 2013, PloS one.
[21] C. Rouzioux,et al. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. , 2013, The Journal of antimicrobial chemotherapy.
[22] Douglas D. Richman,et al. Highly Precise Measurement of HIV DNA by Droplet Digital PCR , 2013, PloS one.
[23] Brigitte Autran,et al. Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study , 2013, PLoS pathogens.
[24] Jerome H. Kim,et al. Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection , 2012, PloS one.
[25] Thierry Prazuck,et al. Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection , 2010, AIDS.
[26] J. Ananworanich,et al. Response to planned treatment interruptions in HIV infection varies across childhood , 2010, AIDS.
[27] Geneviève Boucher,et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.
[28] C. Giaquinto,et al. Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy. , 2006, The Journal of infectious diseases.
[29] Matthew C Strain,et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. , 2005, The Journal of infectious diseases.
[30] R. Siliciano,et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells , 2003, Nature Medicine.
[31] A. Walker,et al. Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy. , 2002, AIDS.
[32] S. Spector,et al. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children. , 2002, The Journal of infectious diseases.
[33] R. Yogev,et al. Infrequent Detection of HIV-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Cell Responses in Young HIV-1-Infected Infants1 , 2001, The Journal of Immunology.
[34] M. Stevenson,et al. Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Control of Viral Replication and Absence of Persistent HIV-1-Specific Immune Responses , 2000, Journal of Virology.
[35] R. Siliciano,et al. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. , 2000, The Journal of clinical investigation.
[36] R. Lempicki,et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[38] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[39] M. Badellino,et al. Pediatric heart transplantation at St. Christopher's Hospital for Children. , 1987, The Journal of heart transplantation.